New Genital Herpes vaccine entrants require improved efficacy to compete
Sanofi’s HSV-529, currently in Phase I of clinical trials, and Immune Design’s G103, a preclinical vaccine candidate, to be tested…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.